Podcasts about multidisciplinary

To choose known suffering over unknown peace reveals a fundamental paradox of human consciousness: our nervous systems and souls often conspire to prioritize certainty over liberation. This phenomenon—reliving toxic patterns because they masquerade as “safety”—operates through interconnected neurobiological, psychological, metaphysical, and sociocultural mechanisms that trap individuals in recursive loops of self-betrayal. 

As someone who goes to yoga a few times a week, I was intrigued at the possibility of integrating it into my therapy practice. Lindsay Watkins is a BCBA and Registered Yoga Teacher (RYT-200) with a passion for blending wellness and applied behavior analysis. Lindsay teaches continuing education (CEUs) to BCBAs on this topic on BehaviorLive (her next training is scheduled for June 2, 2025).Here, Lindsay shares her journey from burning out as a special ed teacher to discovering yoga therapy and figuring out how to apply it to her own clients. We take a look at research studies that show the benefits of using yoga to modify behavior and discuss examples of the techniques in action.Lindsay also shares how she advocates for this outside-the-box approach to therapy, the benefits of yoga across the lifespan, and tips to level up your own yoga practice. #autism #speechtherapy What's Inside:Integrating yoga into therapyResearch on the impact of yoga on behavioral healthBenefits of yoga across the lifespanTips to improve your personal yoga practiceMentioned In This Episode:Lindsay Watkins on Instagram Membership - ABA Speech ABA Speech: Home

How can pediatric and adult urologists team up to tackle complex cancer cases? In this episode of the BackTable Urology, host Dr. Amanda Buchanan, Division Chief of Pediatric Urology at the University of Kentucky, is joined by her colleagues Dr. Patrick Hensley, an adult urologic oncologist, and Dave Rodeberg, Division Chief of Pediatric Surgery. Their discussion centers around the importance of professional collaboration in urologic oncology care in order to improve patient outcomes.---SYNPOSISThe urologists discuss topics such as the experiences and benefits of interdisciplinary collaboration in complex cases and the role of pediatric urologists in treating adolescent and young adult patients. They also provide insights into the Children's Oncology Group (COG) studies and their intersections with adult oncology research. The episode concludes with practical advice for other institutions aiming to improve collaborative efforts between pediatric and adult urology departments.---TIMESTAMPS00:00 - Introduction02:35 - Challenges and Lessons in Multidisciplinary Collaboration08:24 - Pediatric vs. Adult Urologic Oncology11:07- Clinical Trials and Research Collaborations12:49 - Navigating Oncology Groups for Children and Adults19:06 - Collaborative Models in Kidney Cancer Care22:18 - Benefits and Challenges of Collaboration35:24 - Final Thoughts and Recommendations---RESOURCESSociety of Urologic Oncology:https://suonet.org/home.aspxChildren's Oncology Grouphttps://www.childrensoncologygroup.org/

Have you ever considered adding ABA services to your speech therapy practice? Today I had a chat with Quintina Briscoe, founder of Pediatric Speech Lab, who shares her inspiring journey to opening her own clinic. Quintina discusses how she recognized a gap in services for children with autism and the importance of integrating ABA into speech therapy to better support her clients.She reflects on the behavioral challenges many SLPs face and how inclusive, multidisciplinary therapy can make a lasting difference. Quintina also highlights the range of services her clinic offers—from in-clinic and teletherapy sessions to placing facilitators in Baltimore City schools.We also dive into her empowering company culture, rooted in inclusivity, autonomy, transparency, and respect—and how she weaves these values into every layer of her business and team meetings.#autism #speechtherapy What's Inside:Integrating ABA services into speech therapyHow SLPs react to adding ABAThe value of inclusive care Scaling a thriving clinic with integrated ABAMentioned In This Episode:Quintina Briscoe M.S. CCC-SLP (@quintinabriscoeslp) on InstagramMembership - ABA Speech  ABA Speech: Home

CardioNerds Critical Care Cardiology Council members Dr. Gurleen Kaur and Dr. Katie Vanchiere meet with Dr. Yash Patel, Dr. Akanksha, and Dr. Mohammed El Nayir from Trinity Health Ann Arbor. They discuss a case of pulmonary air embolism, RV failure, and cardiac arrest secondary to an ocular venous air embolism. Expert insights provided by Dr. Tanmay Swadia. Audio editing by CardioNerds Academy intern, Grace Qiu. A 36-year-old man with a history of multiple ocular surgeries, including a complex retinal detachment repair, suffered a post-vitrectomy collapse at home. He was found hypoxic, tachycardic, and hypotensive, later diagnosed with a pulmonary embolism from ocular venous air embolism leading to severe right heart failure. Despite a mild embolic burden, the cardiovascular response was profound, requiring advanced hemodynamic support, including an Impella RP device (Abiomed, Inc.). Multidisciplinary management, including fluid optimization, vasopressors and mechanical support to facilitate recovery. This case underscores the need for early recognition and individualized intervention in cases of ocular venous air embolism. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls- Clear Vision, Clouded Heart: Ocular Venous Air Embolism with Pulmonary Air Embolism, RV Failure, and Cardiac Arrest Hypoxia, hypotension and tachycardia in a patient following ocular instrumentation are classic findings suggestive of pulmonary embolism from possible air embolism. The diagnosis of RV failure is based on clinical presentation, echocardiographic findings (such as McConnell's sign), and invasive hemodynamic assessment via right heart catheterization. Mechanical circulatory support can be considered as a temporary measure for patients with refractory RV failure. Central Figure: Approach to Pulmonary Embolism with Acute RV Failure Notes - Clear Vision, Clouded Heart: Ocular Venous Air Embolism with Pulmonary Air Embolism, RV Failure, and Cardiac Arrest 1. What is an Ocular Venous Air Embolism (VAE), and how can it be managed in critically ill patients? An Ocular Venous Air Embolism is defined as the entry of air into the systemic venous circulation through the ocular venous circulation, often during vitrectomy procedures. Early diagnosis is key to preventing cardiovascular collapse in cases of Ocular Venous Air Embolism (VAE).  The goal is to stop further air entry. This can be done by covering the surgical site with saline-soaked dressings and checking for air entry points. Adjusting the operating table can help, especially with a reverse Trendelenburg position for lower-body procedures. The moment VAE is suspected, discontinue nitrous oxide and switch to 100% oxygen. This helps with oxygenation, speeds up nitrogen elimination, and shrinks air bubbles. Hyperbaric Oxygen Therapy can reduce bubble size and improve oxygenation, especially in cases of cerebral air embolism, when administered within 6 hours of the incident. Though delayed hyperbaric oxygen therapy can still offer benefits, the evidence is mixed. VAE increases right heart strain, so inotropic agents like dobutamine can help boost cardiac output, while norepinephrine supports ventricular function and systemic vascular resistance, but this may also worsen pulmonary resistance.  Aspiration of air via multi-orifice or Swan-Ganz catheters has limited success, with success rates ranging from 6% to 16%. In contrast, the Bunegin-Albin catheter has shown more promise, with a 30-60% success rate. Catheterization for acute VAE-induced hemodynamic compromise is controversial, and there's insufficient evidence to support its ...

Slate writer Scaachi Koul unpacks her latest book of essays Sucker Punch, in which she delves into her unexpected birth, the dissolution of her marriage, and how her friends have come to know her as "the divorce doula." Multidisciplinary artist Emma Ruth Rundle explains how she crafted her debut poetry collection The Bella Vista – which touches on love lost, addiction, and discovering oneself – while traveling on tour, then performs “Blooms of Oblivion” from her album Engine of Hell. 

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including:Why early detection is key for improving patient outcomesHow to monitor through use of noninvasive imaging and biopsy per guideline recommendationsHow to coordinate patient care to provide much-needed multidisciplinary careWhat therapies in the pipeline could transform the treatment landscape for this genetic disease PresentersPaula Henao, MDAssistant Professor of MedicineDivision of Pulmonary, Allergy and Critical Care MedicinePenn State Hershey Medical CenterHershey, PennsylvaniaRohit Loomba, MD, MHScProfessor of MedicineChief, Division of Gastroenterology and HepatologyDirector, MASLD Research CenterUniversity of California, San DiegoSan Diego, CaliforniaCheryl Pirozzi, MD, MSAssociate Professor of Internal MedicineDivision of Pulmonary and Critical Care MedicineUniversity of UtahSalt Lake City, UtahCorinne Young, NP, FCCPPresident/FounderAssociation of Pulmonary Advanced Practice ProvidersColorado Springs, ColoradoLink to full program: https://bit.ly/4dgCRnq

Navigating disparities in the diagnosis and treatment of biliary tract cancer (BTC) is essential for improving patient outcomes, ensuring equitable care, and optimizing the patient experience. The Association of Cancer Care Centers (ACCC) remains committed to increasing awareness and disseminating the latest strategies for BTC management. In this episode, CANCER BUZZ explores these issues with Paige Griffith, CRNP, lead oncology nurse practitioner at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, who highlights the vital role of multidisciplinary teams in reducing care fragmentation and streamlining care delivery. CANCER BUZZ also speaks with Chaundra Bishop, a patient with biliary tract cancer, who shares her personal experience confronting systemic barriers—particularly delays and obstacles during the diagnostic process—and offers insights into how addressing such disparities can improve the patient journey for others.   “Everyone plays a role, even from early-stage disease all the way to advanced disease, and having someone help navigate patients through that very complex system is important.” – Paige Griffith, CRNP   “From the patient perspective, I think it's always important to ask for what you need, or ask questions if you don't understand something. Don't, as they say, suffer in silence.” – Chaundra Bishop   Paige Griffith, CRNP  Lead Oncology Nurse Practitioner  Johns Hopkins Sidney Kimmel Comprehensive Cancer Center  Baltimore, MD    Chaundra Bishop  Patient With Biliary Tract Cancer     Resources:  Bile Duct Cancer - MD Anderson Cancer Center - https://bit.ly/42YPRdT Cholangiocarcinoma - NCI - https://bit.ly/44oV4N2

Ever wondered if bringing on dietitians in mental health could transform your group practice—but felt stuck on where to start?  In this episode, I'm sitting down with Jamie Magdic, registered dietitian and group practice owner, to dive deep into the logistics of dietitians in mental health, opportunities, and challenges of creating a true multidisciplinary practice. Jamie shares her experience running a thriving, insurance-based dietitian group and offers key insights into how multidisciplinary therapy can better serve your clients—and how to navigate the practical hurdles like billing, legalities, and team support. If you've been thinking about expanding your practice beyond therapy services, this episode is packed with must-know information, especially when it comes to dietitian insurance coverage and setting up your systems for success. In this episode, you'll learn: What makes bringing on dietitians in mental health so powerful—and why it's a growing trend for group practice owners. The biggest surprises (and headaches) when it comes to dietitian insurance coverage and why medical billing looks very different from therapy billing. How to structure a strong multidisciplinary practice team that ensures dietitians feel supported, legally protected, and able to thrive. The often-overlooked benefits of multidisciplinary team collaboration—and how it elevates client care and boosts outcomes. What systems and experts you need in place to create a sustainable multidisciplinary therapy environment (hint: supervision, billing, and legal guidance are critical!). Tune in to the full episode now to learn exactly how to navigate bringing dietitians in mental health into your practice and unlock the true benefits of multidisciplinary team care!   LINKS: Need extra support? Join The Exchange, a membership community just for group practice owners.  The Group Practice Exchange Programs + Courses The Accountability Equation™ Quiz The Accountability Equation Book Group Practice Forecasting Support GPT   CONNECT WITH MAUREEN WERRBACH & THE GROUP PRACTICE EXCHANGE: Website Facebook Instagram LinkedIn   CONNECT WITH JAMIE MAGDIC: Website Instagram   SPONSORS: TherapyNotes: An EHR software that helps behavioral health professionals manage their practice with confidence and efficiency. Go to therapynotes.com/r/thegrouppracticeexchange for two free months!  GreenOak Accounting: An accounting firm that specializes in working with group practices. Mention TGPE to get $100 off your first month!  

As startups grow, product teams often find themselves caught between speed and structure. In this episode of The Product Experience, Charlotte King, Lead Product Manager at eBay, shares practical insights from her work leading teams through this transition at companies including Moonpig, Flipdish, and ThoughtWorks. Charlotte unpacks how to define product's role during scaleup, build team structure around strategic value, and use tools like Wardley Mapping and Team Topologies to support organisational change. She also introduces the DHM model (Delightful, Hard to copy, Margin-enhancing) and discusses how to make strategy tangible for cross-functional teams. This conversation is especially useful for product leaders, heads of product, and founders navigating scale.Chapters1:13 – Charlotte's background2:36 – Product's role in startups, scaleups and enterprises4:35 – What product teams need to succeed during scale6:42 – Defining product's role as the company grows9:00 – Using Wardley Mapping to assess team maturity14:30 – Creating and communicating guiding principles20:30 – Using the DHM model to prioritise value25:48 – Structuring teams with Team Topologies29:03 – Multidisciplinary collaboration in practice30:41 – Lessons from leading transformation32:30 – Final reflections and takeawaysFeatured Links: Follow Charlotte on LinkedIn | eBay | Wardley Maps | What we learned at #mtpcon London 2025' feature by Kent McDonald and Louron PrattOur HostsLily Smith enjoys working as a consultant product manager with early-stage and growing startups and as a mentor to other product managers. She's currently Chief Product Officer at BBC Maestro, and has spent 13 years in the tech industry working with startups in the SaaS and mobile space. She's worked on a diverse range of products – leading the product teams through discovery, prototyping, testing and delivery. Lily also founded ProductTank Bristol and runs ProductCamp in Bristol and Bath. Randy Silver is a Leadership & Product Coach and Consultant. He gets teams unstuck, helping you to supercharge your results. Randy's held interim CPO and Leadership roles at scale-ups and SMEs, advised start-ups, and been Head of Product at HSBC and Sainsbury's. He participated in Silicon Valley Product Group's Coaching the Coaches forum, and speaks frequently at conferences and events. You can join one of communities he runs for CPOs (CPO Circles), Product Managers (Product In the {A}ether) and Product Coaches. He's the author of What Do We Do Now? A Product Manager's Guide to Strategy in the Time of COVID-19. A recovering music journalist and editor, Randy also launched Amazon's music stores in the US & UK.

Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols Substance Use and Addiction Journal Xylazine in the unregulated drug supply produces significant morbidity and this paper describes utilizing a multidisciplinary team to develop protocols for inpatient setting to manage patients with xylazine exposure. Protocols developed included use of scheduled clonidine or tizanidine to manage withdrawal with hold parameters. As there is no FDA approved immunoassay screen, they recommended assuming xylazine exposure in areas with high prevalence and limited testing. The team also developed guidelines for cases in which surgical interventions would be considered, when to culture wounds, antibiotic usage, and consistent wound care based on size and clinical characteristics. In addition, they developed standardized discharge instructions, including referral to substance use disorder treatment, harm reduction and education around xylazine test strip use.     Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Guest host Kofi Fosu Forson talks with Jenna Basso Pietrobon, a multidisciplinary artist skilled in a variety of mediums including, painting, sculpture, architecture, design, performance and activism. Pietrobon shares with the Whitehot Art World audience her revolutionizing of the mystery of fate, art and destiny. How a trip back to her grandparents home of Nove di Bassano in Italy changed the course of her art platform. Currently based in Paris, she touches on her experience in New York working in a patriarchal system. How trauma from that broadened her activism for women silenced, and oppressed in hope of gender equality. Central in her art experience is how she manages recovery from trauma in an activist and art-making role, building on a form of inclusivity with the involvement of artisans in her art-making process.

My guest this week is multidisciplinary artist Nicholas Galanin.Nicholas is from the sitka tribe of Alaska and has exhibited his works all over the world, from the Whitney Museum and Museum of Modern Art, to the Abu Dhabi Biennial. His work challenges stereotypes of indigenous art while also addressing social and environmental issues.He recently received the Don Tyson Prize for outstanding achievement in American Art from the Crystal Bridges museum.Nicholas and I discuss life in Sitka, embracing cultural heritage, his incredible Never Forget series, fashion brands leveraging indigenous designs and more.*Sponsored by Bezel - the trusted marketplace for buying and selling your next luxury watch 

Living With Risk in the Late Roman World (U Pennsylvania Press, 2025)explores the ever-present experiences of risk that characterized the daily existence of individuals, communities, and societies in the late Roman world (late third century CE through mid-sixth century CE). Recognizing the vital role of human agency, author Cam Grey bases his argument on the concept of the riskscape: the collection of risks that constitute everyday lived experience, the human perception of those risks, and the actions that exploit, mitigate, or exacerbate them. In contrast to recent grand narratives of the fate of the late Roman Empire, Living with Risk in the Late Roman World focuses on the quotidian practices of mitigation and management, foreknowledge and prediction, and mobilization and manipulation of risks at the individual and community levels. Grey illustrates the ubiquity of these practices through a collection of anecdotes that emphasize the highly localized, heterogeneous, and complementary nature of riskscapes: members of local communities enlisting figures of power to neutralize the hazards posed by imminent catastrophes, be it a tsunami, earthquake, or volcanic eruption; Christian holy figures both suffering and imposing bodily affliction as part of their claims to control such hazards and thereby to exercise influence in these communities; intimate experiences of seasonality and weather that shaped local practices of subsistence but also of self-representation; and geographically specific and fiercely contested claims to special knowledge and control of water. Multidisciplinary in its methodology and provocative in its argumentation, Living with Risk in the Late Roman World demonstrates that human communities in the ancient past were inextricably intertwined with the world around them, and that the actions they took simultaneously responded to and shaped the risks—both hazardous and favorable—that they perceived. New Books in Late Antiquity is presented by Ancient Jew Review Cam Grey is Professor of Classics at the University of Pennsylvania Michael Motia teaches in Classics and Religious Studies at UMass Boston Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Living With Risk in the Late Roman World (U Pennsylvania Press, 2025)explores the ever-present experiences of risk that characterized the daily existence of individuals, communities, and societies in the late Roman world (late third century CE through mid-sixth century CE). Recognizing the vital role of human agency, author Cam Grey bases his argument on the concept of the riskscape: the collection of risks that constitute everyday lived experience, the human perception of those risks, and the actions that exploit, mitigate, or exacerbate them. In contrast to recent grand narratives of the fate of the late Roman Empire, Living with Risk in the Late Roman World focuses on the quotidian practices of mitigation and management, foreknowledge and prediction, and mobilization and manipulation of risks at the individual and community levels. Grey illustrates the ubiquity of these practices through a collection of anecdotes that emphasize the highly localized, heterogeneous, and complementary nature of riskscapes: members of local communities enlisting figures of power to neutralize the hazards posed by imminent catastrophes, be it a tsunami, earthquake, or volcanic eruption; Christian holy figures both suffering and imposing bodily affliction as part of their claims to control such hazards and thereby to exercise influence in these communities; intimate experiences of seasonality and weather that shaped local practices of subsistence but also of self-representation; and geographically specific and fiercely contested claims to special knowledge and control of water. Multidisciplinary in its methodology and provocative in its argumentation, Living with Risk in the Late Roman World demonstrates that human communities in the ancient past were inextricably intertwined with the world around them, and that the actions they took simultaneously responded to and shaped the risks—both hazardous and favorable—that they perceived. New Books in Late Antiquity is presented by Ancient Jew Review Cam Grey is Professor of Classics at the University of Pennsylvania Michael Motia teaches in Classics and Religious Studies at UMass Boston Learn more about your ad choices. Visit megaphone.fm/adchoices

Living With Risk in the Late Roman World (U Pennsylvania Press, 2025)explores the ever-present experiences of risk that characterized the daily existence of individuals, communities, and societies in the late Roman world (late third century CE through mid-sixth century CE). Recognizing the vital role of human agency, author Cam Grey bases his argument on the concept of the riskscape: the collection of risks that constitute everyday lived experience, the human perception of those risks, and the actions that exploit, mitigate, or exacerbate them. In contrast to recent grand narratives of the fate of the late Roman Empire, Living with Risk in the Late Roman World focuses on the quotidian practices of mitigation and management, foreknowledge and prediction, and mobilization and manipulation of risks at the individual and community levels. Grey illustrates the ubiquity of these practices through a collection of anecdotes that emphasize the highly localized, heterogeneous, and complementary nature of riskscapes: members of local communities enlisting figures of power to neutralize the hazards posed by imminent catastrophes, be it a tsunami, earthquake, or volcanic eruption; Christian holy figures both suffering and imposing bodily affliction as part of their claims to control such hazards and thereby to exercise influence in these communities; intimate experiences of seasonality and weather that shaped local practices of subsistence but also of self-representation; and geographically specific and fiercely contested claims to special knowledge and control of water. Multidisciplinary in its methodology and provocative in its argumentation, Living with Risk in the Late Roman World demonstrates that human communities in the ancient past were inextricably intertwined with the world around them, and that the actions they took simultaneously responded to and shaped the risks—both hazardous and favorable—that they perceived. New Books in Late Antiquity is presented by Ancient Jew Review Cam Grey is Professor of Classics at the University of Pennsylvania Michael Motia teaches in Classics and Religious Studies at UMass Boston Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/italian-studies

In 2024 Alfred Health launched an innovative multidisciplinary Perioperative Medical Service to improve the care of surgical patients. In this podcast we talk to Nadine Laurent and Stephanie Jinks, Clinical Nurse Consultants on the Perioperative Service, about the pivotal role nursing staff play as part of the perioperative team.

In this episode, a multidisciplinary panel of PE key opinion leaders share insights and challenge perceived myths within the landscape of PE real world evidence and care. Listen in for the latest data, contemporary treatment strategies, and preview anticipated future developments in this rapidly evolving field of PE.

This week we bring together urologists and radiologists to work towards a shared goal of innovating on kidney cancer care. Dr. Jason Abel, Professor of Urology and Radiology at the University of Wisconsin, and Dr. Louis Hinshaw, Section Chief of Abdominal Imaging Intervention at the University of Wisconsin, join our host Dr. Ruchika Talwar for a multidisciplinary conversation regarding the treatment of renal tumors. --- SYNPOSIS Their discussion covers the history and benefits of collaboration between urology and interventional radiology (IR), advances in image-guided procedural technologies, and the importance of teamwork in improving patient outcomes. The episode also considers the encouraging, but limited data in IR treatments such as microwave ablation and discusses the lasting role for surgery. Finally, Dr. Abel and Dr. Hinshaw share their experiences in establishing a successful interdisciplinary kidney cancer program. Ultimately, they conclude that the future of renal tumor treatment lies not in silos, but in collaboration. --- TIMESTAMPS 00:00 - Introduction 04:04 - Collaboration Between Urologists and Interventional Radiologists 05:58 - Advancements in Ablation 10:05 - Patient Selection 15:19 - Technical Considerations 26:57 - Post-Ablation Surveillance and Recurrence Management 33:19 - Conclusion

This week we bring together urologists and radiologists to work towards a shared goal of innovating on kidney cancer care. Dr. Jason Abel, Professor of Urology and Radiology at the University of Wisconsin, and Dr. Louis Hinshaw, Section Chief of Abdominal Imaging Intervention at the University of Wisconsin, join our host Dr. Ruchika Talwar for a multidisciplinary conversation regarding the treatment of renal tumors. --- SYNPOSIS Their discussion covers the history and benefits of collaboration between urology and interventional radiology (IR), advances in image-guided procedural technologies, and the importance of teamwork in improving patient outcomes. The episode also considers the encouraging, but limited data in IR treatments such as microwave ablation and discusses the lasting role for surgery. Finally, Dr. Abel and Dr. Hinshaw share their experiences in establishing a successful interdisciplinary kidney cancer program. Ultimately, they conclude that the future of renal tumor treatment lies not in silos, but in collaboration. --- TIMESTAMPS 00:00 - Introduction 04:04 - Collaboration Between Urologists and Interventional Radiologists 05:58 - Advancements in Ablation 10:05 - Patient Selection 15:19 - Technical Considerations 26:57 - Post-Ablation Surveillance and Recurrence Management 33:19 - Conclusion

Jamie Ku, MD joins to discuss the latest advancements in treating oropharyngeal squamous cell carcinoma, including transoral robotic surgery, and her recent ASCO publication. The episode also explores Dr. Ku's VeloSano-funded research on improving outcomes for tongue cancer patients and reducing treatment burden for oral cancer patients.

What does it take to deliver truly personalized, multidisciplinary care in testicular cancer? Get an inside look in this episode of BackTable Urology, where renowned testicular cancer experts Dr. Nabil Adra and Dr. Richard Matulewicz join host Dr. Aditya Bagrodia for a virtual tumor board session on the nuanced management of germ cell tumors. This episode was produced in collaboration with the Society of Urologic Oncology. --- SYNPOSIS The expert panel uses specific patient cases to review their decision-making processes on the use of surgery, chemotherapy, and radiation. They highlight the importance of a multidisciplinary approach, particularly for advanced disease and challenging surgical scenarios. The episode reviews patient-specific factors, standard treatment protocols, post-treatment surveillance, and the latest research. This episode also highlights the benefits of personalized cancer care. --- TIMESTAMPS 00:00 - Introduction 01:45 - Case Presentation: 23-Year-Old Male with Testicular Mass 02:14 - Initial Counseling and Management 04:03 - Orchiectomy and Post-Surgery 06:27 - Stage I Management 10:00 - Surveillance and Adjuvant Therapy 13:56 - Recurrence 23:13 - Case Study: 44-Year-Old with Non-Seminoma 28:14 - Case Study: 17-Year-Old with Developmental Delay and Cancer 29:42 - Chemotherapy Decisions 30:31 - Brain Imaging and Metastasis Predictions 33:54 - Chemotherapy Regimens 35:53 - Monitoring and Salvage Therapy 45:01 - Case Study: 21-Year-Old with Teratoma 55:21 - Concluding Thoughts --- RESOURCES Society of Urologic Oncology: https://suonet.org/home.aspx

Multidisciplinary artist Spinks shares her journey through dance, acting, writing and ceramics as a queer, biracial woman. She shares why she walked away from musical theater, how she found freedom in commercial work, and the profound reason she hasn't returned to a dance class…yet. Spinks and Jess also discuss the impact of capitalism on joy, creativity, and a building a career in the arts. This episode is for you if you're looking to define success on your own terms, find fulfillment in your chosen craft, and carve your own unique path. Time Stamps & Topics00:00 Introduction to Spinks: A Multidisciplinary Artist01:38 Spinks' Human Bio02:53 The Journey of a Multifaceted Artist11:04 Navigating Musical Theater18:34 The Intersection of Various Disciplines24:22 Commercial Work vs. Artistic Expression30:57 Vulnerability in Performance34:54 The Joy of Art & Creating Without Capitalism35:22 Rediscovering Joy in Dance39:00 Navigating Fear and Re-Entering Dance45:02 The Healing Power of Dance52:04 Cultivating a Sustainable Artistic Career57:02 Finding Contentment Amidst ChaosAbout Spinks:Spinks is a multi-disciplinary artist based in Brooklyn. First a musician, then a dancer, and eventually an actor, Spinks has found herself entirely devoted to the performing and visual arts her entire life. Her work has been displayed in various theaters, on stages big and small, in cinemas, and in the quiet pages of several magazines all around the world. On screen, she's been lucky enough to work with the likes of Google, Clinique, Planned Parenthood, Bio Glitz, and Cocoa Jones (to name a few). Her writing can be found published in FROTH Magazine, Strong Young Thing Magazine, Mixed Mag, and Issues 1-3 of Susie Magazine. Her ceramics have been featured by Florence Contemporary Art Gallery and American Design Club. When not working as an interpretive artist, she can be found experimenting in all things performing and media with her production company, VERNE.  

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.

Are you up to date on the most optimal management of patients with early-stage ALK-positive non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 3/24/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/preeclampsia-biomarker-screening-every-trimester-2025a100065r?ecd=bdc_podcast_libsyn_mscpedu

In this heartfelt conversation, Glasgow-based designer Chris Wilson shares his journey as the one-person creative studio. He discusses his decision to embrace his solo status rather than pretending to be a larger agency, his traumatic experience being attacked with a knife as a university student, and how work became a crutch that ultimately led to burnout and hospitalisation. Chris opens up about discovering therapy later in life, managing client expectations by setting boundaries, and his ongoing evolution as a designer navigating new technologies and personal growth. His story reveals the challenges and rewards of running a small design business while prioritizing well-being.Key TakeawaysBeing authentic about running a solo studio created more trust with clients than pretending to be larger.Work can become a dangerous crutch that helps avoid dealing with emotional trauma.Setting clear boundaries with clients (four-day workweek, email-only communication) helped establish healthier work patterns.Traumatic events can significantly impact creative confidence and career choices.It's important to recognize burnout warnings before health deteriorates seriously.Therapy can be transformative even years after experiencing trauma.Embracing technological change (like AI) is essential for staying relevant in the creative industry.Finding a balance between personal development, client work, and emotional well-being is an ongoing journey.Small studios can build meaningful client relationships by guiding them through the entire creative process.Self-acceptance is crucial for both personal health and authentic creative work. Mindful Creative: How to understand and deal with the highs and lows of creative life, career and business Paperback and Kindle > https://amzn.to/4biTwFcFree audiobook (with Audible trial) > https://geni.us/free-audiobookSigned books https://novemberuniverse.co.ukLux Coffee Co. https://luxcoffee.co.uk/ (Use: PODCAST for 15% off)November Universe https://novemberuniverse.co.uk (Use: PODCAST for 10% off)

Nonepileptic events are prevalent and highly disabling, and multiple pathophysiologic mechanisms for these events have been proposed. Multidisciplinary care teams enable the efficient use of individual expertise at different treatment stages to address presentation, risk factors, and comorbidities.   In this episode, Kait Nevel, MD, speaks with Adriana C. Bermeo-Ovalle, MD, an author of the article “A Multidisciplinary Approach to Nonepileptic Events,” in the Continuum® February 2025 Epilepsy issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Bermeo-Ovalle is a professor and vice-chair for Faculty Affairs in the Department of Neurological Sciences at Rush University Medical Center in Chicago, Illinois. Additional Resources Read the article: A Multidisciplinary Approach to Nonepileptic Events Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Full episode transcript available here Dr. Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum Journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Nevel: Hello, this is Dr Kait Nevel. Today I'm interviewing Dr Adriana Bermeo about her article on a multidisciplinary approach to nonepileptic events, which she wrote with Dr Victor Petron. This article appears in the February 2025 Continuum issue on epilepsy. Welcome to the podcast, and please introduce yourself to our audience. Dr Bermeo-Ovalle: Hello Dr Neville, it's a pleasure to be here. Thank you very much for inviting me. My name is Adriana Bermeo and I'm an adult epileptologist at Rush University Medical Center in Chicago, and I am also the codirector of the NEST clinic, which is a treatment clinic for patients with nonepileptic seizures within our level four epilepsy center. Dr Nevel: Wonderful. Well, thank you so much for being here, and I can't wait to talk to you about your article and learn a little bit about NEST, maybe, during our conversation, and how you approach things. To start us off talking about your article today, could you share with us what you think is the most important takeaway from your article for the practicing neurologist? Dr Bermeo-Ovalle: Wonderful. There's some messages that I would like people to get from working with patients with functional neurologic disorders in general. The first one is that functional neurologic disorders are very common in presentation in the neurologic clinic, almost no matter what your practice of self-specialty care is. The second is that for people who treat patients primarily with seizures or epilepsy, they account for between 5 to 10% of our patients in the clinic, but about 30% of our patients in our epilepsy monitoring unit because the seizures typically do not respond to anti-seizure medication management. Also, that in order to diagnose them, you don't need to have a neuropsychological stress already be available for the patient or the clinician. And the most important thing is that there are available treatments for these patients and that there are options that we can offer them for them to have less seizures and to be more integrated to whatever activities they want to get integrated. Dr Nevel: Wonderful. What do you think a practicing neurologist might find surprising after reading your article? Dr Bermeo-Ovalle: I think still many neurologists feel very hopeless when they see patients with these conditions. They do not have very good answers right away for the patients, which is frustrating for the neurologist. And they don't think there's too much they can do to help them other than send them somewhere else, which is very difficult for the neurologist and is crushing to the patients to see these doctors that they're hoping to find answers to and then just find that there's not much to do. But what I want neurologists to know is that we are making strides in our understanding of the condition and that there are effective treatments available. And I hope that after reading this and engaging with this conversation, they will feel curious, even hopeful when they see the next patient in the clinic. Dr Nevel: Yeah, absolutely. I find the history of nonepileptic seizures really interesting and I enjoyed that part of your article. How has our understanding of nonepileptic seizures evolved over the centuries, and how does our current understanding of nonepileptic seizures inform the terminology that we use? Dr Bermeo-Ovalle: Yeah. The way we name things and the way we offer treatment goes along to how we understand things. So, the functional seizures and epileptic seizures were understood in ancient times as possession from the spirits or the demons or the gods, and then treatments were offered to those kind of influences and that continues to happen with functional seizures. So, we go through the era when this was thought to be a women-only condition that was stemming from their reproductive organs and then treatments accordingly were presented. And later on with Charcot and then Freud, they evolved to even conversion disorders, which is one understanding the most conversion disorders, which is one of the frameworks where this condition has been treated with psychotherapy, psychoanalytic psychotherapy. And in our current understanding, we understand functional neurologic disorders in general as a more like a connection, communication network disorder, between areas of the brain that modulate emotional processing and movement control. And therefore, our approach these days is much more geared towards rehabilitation. You know, I think that's the evolution of thinking in many different areas. And as we learn more, we will be acquiring more tools to help our patients. Dr Nevel: Yeah, great. Thanks so much for that answer. Just reading the historical information that you have in your article, you can imagine a lot of stigma with this diagnosis too over time, and that- I think that that's lessening. But I was wondering if you could talk about that a little bit. How do we approach that with our patients and loved ones, any stigma that they might feel or perceive from being diagnosed with nonepileptic seizures? Dr Bermeo-Ovalle: Thank you for asking that question. Stigma is actually an important problem even for people living with epilepsy. There's still a lot of misunderstanding of what epilepsy is and how it affects people, and that people living with epilepsy can live normal, healthy lives and do everything they want to do with appropriate treatment. And if a stigma is still a problem with epilepsy, it is a huge problem for patients living with functional neurologic symptoms in general, but particularly with functional seizures or nonepileptic seizures. Because the stigma in this population is even perpetuated by the very people who are supposed to help them: physicians, primary care doctors, emergency room doctors. Unfortunately, the new understanding of this condition has not gotten to everybody. And these patients are often even blamed for their symptoms and for the consequences of their symptoms and of their seizures in their family members, in their job environment, in their community. Living with that is really, really crushing, right? Even people talk about, a lot about malingering. They come back about secondary gain. I can tell you the patients I see with functional seizures gain nothing from having this condition. They lose, often, a lot. They lose employment, they lose ability to drive. They lose their agency and their ability to function normally in society. I do think that the fight- the fighting of stigma is one that we should do starting from within, starting from the healthcare community into our understanding of what these patients go through and what is causing their symptoms and what can we do to help them. So there's a lot of good work to be done. Dr Nevel: Absolutely. And it starts, like you said, with educating everybody more about nonepileptic seizures and why this happens. The neurobiology, neurophysiology of it that you outlined so nicely in your article, I'm going to encourage the listeners to look at Figure 1 and 4 for some really nice visualization of these really complex things that we're learning a lot about now. And so, if you don't mind for our listeners, kind of going over some of the neurobiology and neurophysiology of nonepileptic seizures and what we're learning about it. Dr Bermeo-Ovalle: Our understanding of the pathophysiology of functional neurologic seizure disorder is in its infancy at this point. The neurobiological processes that integrate emotional regulation and our responses to it, both to internal stimuli and to external stimuli and how they affect our ability to have control over our movement---it's actually amazing that we as neurologists know so little about these very complex processes that the brain do, right? And for many of us this is the reason why we're in neurology, right, to be at the forefront of this understanding of our brain. So, this is in that realm. It is interesting what we have learned, but it's amazing all that we have to learn. There is the clear relationship between risk factors. So, we know patients with functional neurologic symptom disorder and with functional seizures, particularly in many different places in the world with many different beliefs, relationship to their body, to their expression of their body, have this condition no matter how different they are. And also, we know that they have commonalities. For example, traumatic experiences that are usually either very strong traumatic experiences or very pervasive traumatic experiences or recurrent over time of different quality. So, we are in the process of understanding how these traumatic experiences actually inform brain connectivity and brain development that result in this lack of connections between brain areas and the expression of them, and that result in this kind of disorder. I wish I can tell you more about it or that I would understand more about it, but I am just grateful for the work that has been done so that we can understand more and therefore have more to offer to these patients and their families and their communities that are support. Dr Nevel: Yeah, absolutely. That's always the key, and just really exciting that we're starting to understand this better so that we can hopefully treat it better and inform our patients better---and ourselves. Can you talk to us a little bit about the multidisciplinary team approach and taking care of patients with nonepileptic seizures? Who's involved, what does best practice model look like? You have a clinic there, obviously; if you could share with us how your clinic runs in the multidisciplinary approach for care of these patients? Dr Bermeo-Ovalle: The usual experience of patients dealing with functional seizures, because this is a condition that has neurological symptoms and psychiatric symptoms, is that they go to the neurologist and the neurologist does not feel sufficiently able to manage all the psychiatric comorbidities of the condition. So, the patient is sent to psychiatry. The psychiatry really finds themselves very hopeless into handling seizures, which is definitely not their area of expertise, and these patients then being- “ping-ponging” from one to the other, or they are eventually sent to psychotherapy and the psychotherapist doesn't know what they're dealing with. So, we have found with- and we didn't come up with this. We had wonderful support from other institutions who have done- been doing this for a longer time. That bringing all of this specialty together and kind of situating ourselves around the patient so that we can communicate our questions and our discrepancies and our decision between who takes care of what without putting that burden on the patient is the best treatment not only for the patient, who finally feels welcome and not burden, but actually for the team. So that the psychiatrist and the neurologist support the psychotherapist who does the psychotherapy, rehabilitation, mind the program. And we also have the support and the involvement of neuropsychology. So, we have a psychiatrist, a neurologist, social worker, psychotherapist and neuropsychology colleagues. And together we look at the patient from everywhere and we support each other in the treatment of the patient, keeping the patient in the middle and the interest of the patient in the middle. And we have found that that approach has helped our patients the best, but more importantly, makes our job sustainable so that none of us is overburdened with one aspect of the care of the patient and we feel supported from the instances that is not our most comfortable area. So that is one model to do it. There's other models how to do it, but definitely the interdisciplinary care is the way to go so far for the care of patients with functional neurologic symptom disorders and with functional seizures or nonepileptic seizures in particular. Dr Nevel: Yeah, I can see that, that everybody brings their unique expertise and then doesn't feel like they're practicing outside their, like you said, comfort zone or scope of practice. In these clinics---or maybe this happens before the patient gets to this multidisciplinary team---when you've established a diagnosis of nonepileptic seizures, what's your personal approach or style in terms of how you communicate that with the patient and their loved ones? Dr Bermeo-Ovalle: It is important to bring this diagnosis in a positive term. You know, unfortunately the terminology question is still out and there's a lot of teams very invested into how to better characterize this condition and how to- being told that you don't have something is maybe not that satisfying for patients. So, we are still working on that, but we do deliver the diagnosis in positive terms. Like, this is what you have. It's a common condition. It's shared by this many other people in the world. It's a neuropsychiatric disorder and that's why we need the joint or collaborative care from neurology and psychiatry. We know the risk factors and these are the risk factors. You don't have to have all of them in order to have this condition. These are the reasons why we think this is the condition you have. There is coexisting epilepsy and functional seizures as well. We will explore that possibility and if we get to that conclusion, we will treat these two conditions independently and we- our team is able to treat both of them. And we give them the numbers of our own clinic and other similar clinics. And with that we hope that they will be able to get the seizures under better control and back to whatever is important to them. I tell my trainees and my patients that my goals of care for patients with functional seizures are the same as my patients with epileptic seizures, meaning less seizures, less disability, less medications, less side effects, less burden of the disease. And when we communicate it in that way, patients are very, very open and receptive. Dr Nevel: Right. What do you think is a mistake to avoid? I don't know if “mistake” is necessarily the right word, but what's something that we should avoid when evaluating or managing patients with nonepileptic seizures? What's something that you see sometimes, maybe, that you think, we should do that differently? Dr Bermeo-Ovalle: I think the opportunity of engaging with these patients is probably the hardest one. Because neurologists have the credibility, they have the relationship, they have- even if they don't have a multi-disciplinary team all sitting in one room, they probably have some of the pieces of this puzzle that they can bring together by collaborating. So, I think that missing the opportunity, telling the patient, this is not what I do or this is not something that belongs to me, you need to go to a mental health provider only, I think is the hardest one and the most disheartening for patients because our patients come to us just like all patients, with hopes and with some information to share with us so that we can help them make sense of it and have a better way forward. We as neurologists know very well that we don't have an answer to all our patients, and we don't offer zero seizures to any of our patients, right? We offer our collaborative work to understand what is going on and a commitment to walk in the right direction so that we are better every day. And I do think wholeheartedly that that is something that we can offer to patients with functional seizures almost in any environment. Dr Nevel: Yeah, absolutely. And using that multidisciplinary approach and being there with your patient, moving forward in a longitudinal fashion, I can see how that's so important. What do you find most challenging and what do you find most rewarding about caring for patients with nonepileptic seizures? Dr Bermeo-Ovalle: The thing that I find more challenging are the systemic barriers that the system still places. We discuss with the patients, what is the right time to go to the emergency room or not? Because the emergency room may be a triggering environment for patients with functional seizures and it may be a place where not everybody is necessarily attuned to have this conversation. Having said that, I never tell any of my patients not to go to the emergency room because I don't know what's happening with them. As a matter of fact, we're getting a lot of information on high mortality rates in patients with functional seizures, and it's not because of suicide and is probably not related to the seizure. Maybe this is---you know, this is speculation on my part---that is because they get to more severe conditions in other things that are not the functional seizures because they just experienced the healthcare system as very hostile because we are very in many instances. So, navigating that is a little bit difficult, and I try to tell them to have the doctors call me so that I can frame it in a different way and still be there for them. But I can tell you this clinic is the most rewarding clinic of all my clinical activities. And I love with all my heart being an epileptologist and seeing my patients with epilepsy. But the number of times my patients with functional seizures say, nobody had ever explained this to me, nobody had ever validated my experience in front of my family so that I'm not- like, feel guilty myself for having this episode, I can't tell you how many times. And obviously patients who come to the nonepileptic seizure clinic already know that they come to the nonepileptic seizure clinic, so that- you can say it's a selection of patients that are already educated in this condition to come to the clinic. But I would love everybody to know managing this population can be enormously, enormously satisfying and rewarding. Dr Nevel: Especially for, I imagine, patients who have been in and out of the ER, in and out of the hospital, or seen multiple providers and make their way to you. And you're able to explain it in a way that makes sense and hopefully reduces some of that stigma maybe that they have been feeling. Dr Bermeo-Ovalle: And along with that, iatrogenic interventions, unnecessary intubations, unnecessary ICUs; like, so much. And I think, I have no superpower to do that other than understanding this condition in a different way. And by I, I mean all the providers, because I'm not alone in this. There's many, many people doing excellent work in this state. And we just need to be more. Dr Nevel: Yeah, sure. Absolutely. So, on that note, what's next in research, or what do you think will be the next big thing? What's on the horizon in this area? Dr Bermeo-Ovalle: I think the community in the functional neurologic disorder community is really hopeful that more understanding into the neurobiology of this condition will bring more people over and more neurologists willing to take it on. There was an invitation from the NIH, I think, about four or five years ago to submit proposals for research in this area in particular. So, all of those studies must be ongoing. I'm much more a clinician than a researcher myself, but I am looking forward to what all of that is going to mean for our patients. And for- I think there's other opportunities in that further understanding of the clinical manifestations of many other conditions, and for our understanding of our relationship with our patients. I feel we are more attuned to align with a disease that, when the experience of the patient- and with a disease like this, a condition like this one, we have to engage with the personal experience of the patient. What I mean by that is that we are more likely to say,  I'm an epileptologist, I'm an MS doctor, you know, and we engage with that condition. This condition, like, just makes us engaging with the symptom and with the experience of the person. And I think that's a different frame that is real and rounded into the relationship with our patients. So, I think there's so much that we can learn that can change practice in the future. Dr Nevel: Yeah. And as your article, you know, outlines, and you've outlined today during our discussion, that- how important this is for the future, that we treat these patients and help them as much as we can, that comes with understanding the condition better, because wow, I was really surprised reading your article. The mortality associated with this, the healthcare costs, how many people it affects, was just very shocking to me. So, I mean, this is a really important topic, obviously, and something that we can continue to do better in. Wonderful. Well, thank you so much. It's been really great talking to you today. Dr Bermeo-Ovalle: Thank you, Katie, I appreciate it too. Dr Nevel: So again, today I've been interviewing Dr Adriana Bermeo about her article on a multidisciplinary approach to nonepileptic events, which she wrote with Dr Victor Petron. This article appears in the most recent issue of Continuum on epilepsy. Be sure to check out Continuum audio episodes from this and other issues. And thank you to our listeners for joining today.  Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Updates from the 2024 ESC and AHA Scientific Statements on Cardiac Sarcoidosis   Guest: Leslie T. Cooper Jr., M.D. Host: Kyle W. Klarich, M.D.   Cardiac sarcoidosis is a systemic, chronic inflammatory disorder characterized by non-caseating, epithelioid cell granulomas that may involve many tissues and organs. The Heart Rhythm Society criteria for diagnosis of cardiac sarcoidosis require a biopsy-proven diagnosis of extra-cardiac sarcoidosis. If extra-cardiac sarcoidosis is confirmed, CS is highly probable when there is evidence of the following: (a) rhythm abnormalities in either ECG or Holter monitoring such as advanced AVB (Mobitz type II second-degree or third-degree AVB), sustained VT, and (b) LV dysfunction on echocardiography or CMR (LVEF

Are You Seeing Multiple Providers but Still Feeling Stuck in Your Concussion Recovery? You're not alone. Many concussion patients work with different professionals—physical therapists, chiropractors, nutritionists, doctors—but those providers often don't talk to each other. That lack of communication can slow your healing. And here's the kicker: It doesn't have to be that way. In this episode, we're taking a fresh look at how to build a multidisciplinary team that actually works together to support your recovery. We'll talk about the importance of having a “quarterback” to help coordinate care, why networking between providers is key, and how you can make sure you're getting the best possible treatment. BY THE TIME YOU FINISH LISTENING, YOU'LL DISCOVER: ✅ Why a truly collaborative team can be a game-changer in your recovery ✅ The role of a “quarterback” provider and how they can streamline your care ✅ How to make sure your healthcare team is actually communicating with each other ✅ The power of networking and why building relationships with providers leads to better care Your recovery deserves more than a disconnected team—let's build one that works for you, not against you.

How does multimorbidity impact the progression from psoriasis to psoriatic arthritis? Can early identification of chronic conditions help prevent psoriatic arthritis in high-risk patients?In this episode of Inside GRAPPA, host Dr. Mio Nakamura sits down with Dr. Paras Karmacharya, recipient of a GRAPPA Annual Pilot Research Grant. He presented his findings at the 2024 GRAPPA Annual in Seattle and shares his groundbreaking study with us on "Multimorbidity and Psoriasis as a Risk Factor for Psoriatic Arthritis." Dr. Karmacharya discusses his personal journey into psoriatic arthritis research, how his study leveraged the Rochester Epidemiology Project, and what the findings mean for the future of patient care. He also explores: ✔️ What multimorbidity really means in psoriatic disease ✔️ The connection between chronic conditions and psoriatic arthritis risk ✔️ How his study design helped uncover key insights ✔️ The clinical implications for screening, early intervention, and patient educationKey Takeaways

The Rush Neurosurgery program is a nationally recognized leader in neurosurgical care, incorporating the most advanced surgical and nonsurgical therapies to treat brain, spine and nervous system conditions. Rush neurosurgeons collaborate with neurologists, neuroradiologists, physiatrists and otolaryngologists to address these conditions, providing patients with individualized and disease-specific approaches in several subspecialty clinics and centers across Chicago and surrounding communities. Vincent Traynelis, MD, is the interim chair of the Department of Neurosurgery at Rush University Medical Center. He is also the vice chair of academic affairs and the director of the Spine and Peripheral Nerve Section at Rush. “At Rush, our surgeons are highly trained and specialized in performing skull base surgery. They have the skill set to handle complex tumors and they work hand –in hand with our colleagues in otolaryngology. They discuss these tumors preoperatively. They consider all of the options. They have the latest equipment. And I believe what sets us apart is that we have the right people with the right focus who can get along and work well together.”

Although she has a broad-based taste in music that spans numerous genres, Sonic Griot is best known for curating vibes with African alternative and electronic dance music, her eclectic aesthetic, love of dance, energetic performance and deep connection with her audience. A member of the Afrique Like Me collective, Sonic Griot is also a corporate by day, balancing her passion for music with helping companies grow and implement strategy.

On this episode, Tom goes "On the Aisle" with actor, intimacy director, singer, educator, Claire Wilcher. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of the Accounting Influencer podcast, Rob Brown discusses KPMG's groundbreaking move to become the first major accounting firm in the US to own a law firm, following new laws in Arizona that allow non-lawyers to own law firms. This shift is driven by client demand for integrated services, advancements in technology, and the lucrative nature of legal services. Brown emphasizes the implications for accounting professionals, including the need for multidisciplinary skills, tech literacy, and ethical considerations. He encourages listeners to stay informed, expand their expertise, and build their influence to remain relevant in a rapidly changing landscape.TakeawaysKPMG is pioneering a significant shift in the accounting profession by owning a law firm.The relaxation of laws in Arizona is a game changer for legal services.Client demand for integrated solutions is a major driver of this change.Technology and process expertise are essential for modern accounting firms.Legal services are lucrative, presenting a growth opportunity for accounting firms.Multidisciplinary teams are becoming the norm in professional services.Tech skills are crucial for accountants to stay competitive.Ethical scrutiny will increase with the blending of accounting and legal services.Staying informed about industry trends is vital for accounting professionals.Building influence and expanding expertise will help accountants navigate future changes.You can check out the video version of this with visuals and graphics here on YouTube:https://youtu.be/vdufliwlx2o◣━━━━━━━━━━━━━━━━━━━━◢The Accounting Influencers Podcast, hosted by Rob Brown, is one of the world's leading shows for accounting leaders, professionals, finance specialists, software vendors, tech providers and influencers. Thanks to our sponsors:ADVANCETRACK OUTSOURCING. Transform your accounting firm with AdvanceTrack. Our top-tier offshoring solutions free your team from mundane tasks, allowing you to focus on growth and client engagement. Experience seamless scalability and expert support. Visit advancetrack.com and elevate your practice today. https://www.advancetrack.comIf you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Rob Brown on LinkedIn and his team will reach out to fix up a chat to explore. https://www.linkedin.com/in/therobbrownYou can also check out all shows on the Accounting Influencers YouTube Channel:https://bit.ly/AI-youtube

In conversation with Thuli Mjwara In this episode of Africa Rights Talk, we pay tribute to the life and work of Imam Muhsin Hendricks, a pioneering queer Muslim leader who dedicated his life to fostering inclusivity within faith communities. Our guest, Thuli Mjwara, reflects on his profound impact, highlighting his commitment to radical love, interfaith dialogue, and creating safe spaces for marginalized people. She explores his unique approach to activism—one rooted in softness, connection, and unwavering faith. Thuli also discusses the ongoing work needed to honour Imam Hendricks' legacy, from advocating for inclusivity in religious spaces to ensuring activism also cultivates healing and joy. As we grapple with his tragic loss, the Queer Interfaith Collective has issued a call to action, urging those inspired by Imam Hendricks' work to advocate for the inclusion of marginalized individuals in faith communities, foster interfaith dialogue that bridges differences rather than deepens divides and stand against hatred and violence, refusing to be silenced. Please use the hashtags #JusticeForImamHendricks and #CompassionCentredIslam to amplify his message.   Miss Nokuthula (Thuli) Mjwara is the strategic advocacy coordinator at Inclusive and Affirming Ministries (IAM) Western Cape. With the vision of addressing religious-based homophobia, she works at the intersections of gender, religion, and human rights by facilitating processes that are community-based. Collaborating with civil society partners, she coordinates interventions that promote awareness on diversity, embodied leadership, advocacy, and eradicating conversion practices across Africa. Also, Thuli is a 2022 Outright International United Nations Religion fellow and a seasoned facilitator- accredited by the South African Qualifications Authority (SAQA). She has served on Provincial, National and Regional forums advocating for the rights of Lesbian, Gay, Bisexual, Transgender, and Intersex (LGBTI+) communities. With over 13 years' work experience, she has worked with youth-at risk, sentenced offenders, LGBTI+ youth and their families. In relation to HIV prevention and vaccine research, she has been a member of the Groote Schuur clinical research site community advisory board (CAB) from 2018, serving as its chairperson from 2020-2022. Thuli is currently pursuing her master's degree (MPhil) in Multidisciplinary human rights with the Centre for Human rights (University of Pretoria). She is a queer, Afro- feminist, with a passion for the realization of an equal society, where human dignity and rights are respected and affirmed across all communities.     This conversation was recorded on 27 February 2025.   Youtube: https://youtu.be/MpQFogU6lns Music and news extracts: Inner Peace by Mike Chino https://soundcloud.com/mike-chinoCreative Commons — Attribution-ShareAlike 3.0 Unported — CC BY-SA 3.0 http://creativecommons.org/licenses/b...Music promoted by Audio Libraryhttps://youtu.be/0nI6qJeqFcc Limitless https://stock.adobe.com/za/search/audio?k=452592386  

Mariana Muñoz-Gomez wears many hats. Gomez is a Winnipeg-based artist, writer, zine maker and curator who intricately weaves personal narratives with collective histories in their lens-based practice. In today's episode, Gomez shares what it is like to work for yourself as an artist interested in exploring many directions. Gomez' exploration of identity, colonialism, and capitalist structures is not just academic; it's a deeply personal reflection on individual and collective histories that have impacted many people around the world. Gomez' work urges us to reflect on their own connections to place and history. By employing a variety of media—ranging from photography to zines—Gomez examines how art can aid memory and resistance, offering new perspectives on our shared experiences.During our discussion, Gomez shares the motivations behind their work and how they harness the power of art to question societal norms through a relational lens. The episode shines a spotlight on the role of the curator, where Gomez emphasizes the importance of representation and care for the artists involved, particularly BIPOC voices. Alongside this, Gomez reveals the discipline and organisation required to be a freelancer, sharing how the least glamorous parts of being an artist are almost as important as the art itself. They also offer fascinating insights into their recent curatorial projects and the journey of creating Carnation Zine, a zine uplifting marginalised artists. Listeners will gain a deeper understanding of how art can provoke thought and inspire action within communities while navigating the complexities of a creative career. Don't miss this opportunity to engage with Gomez' journey as they pave the way for meaningful dialogues in contemporary art. Subscribe now and be part of the conversation!  Connect with us:Madison Beale, HostCroocial, ProductionBe a guest on The Artalogue Podcast

In this week's episode, our medical student host interviews Dr. JP Dunn, a uveitis specialist at Wills Eye Hospital. He teaches us about uveitis, ocular inflammation, and the delivery of multidisciplinary care within uveitis. After listening to this episode, you will have a better understanding of how to approach a patient presenting to clinic with ocular inflammation and the different conditions seen by a uveitis specialist.

Dr. Chris Holsinger shares the new guideline from ASCO on transoral robotic surgery (TORS) for patients with oropharyngeal squamous cell carcinoma. He reviews the evidence-based recommendations on baseline assessment, the role of TORS in HPV-positive and HPV-negative disease and in the salvage/recurrent setting, which patients are eligible or ineligible for TORS, and the role of adjuvant therapy. He discusses the importance of multidisciplinary collaboration and shared decision-making between patients and their clinicians. Read the full guideline, “Transoral Robotic Surgery in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline.”   TRANSCRIPT This guideline, clinical tools, and resources are available at asco.org. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology.   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts, delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts.    My name is Brittany Harvey and today I'm interviewing Dr. Chris Holsinger from Stanford University, lead author on “Transoral Robotic Surgery in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline.” Thank you for being here today, Dr. Holsinger. Dr. Chris Holsinger: Thanks, Brittany. We've been working together for years on these guidelines and what a pleasure to get to meet you at least virtually today. Brittany Harvey: Yes, it's great to have you on. And then just before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Holsinger, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So let's jump into this important guideline. Dr. Holsinger, to start us off, can you provide an overview of both the scope and purpose of this guideline? Dr. Chris Holsinger: Absolutely. And again, thanks for the opportunity to be here, Brittany. I appreciate the invitation to participate in the ASCO Guidelines and to work with the great people on this paper that's now out there. I think it's a really important guideline to be published because it really talks about surgery, specifically transoral robotic surgery, a minimally invasive technique, as a new way to treat head and neck cancer. Why that's so important is that what is now known as head and neck cancer is completely different than what we saw even 25 years ago. Around the turn of the century, some really thoughtful epidemiologists working at Hopkins and UW in Seattle started to see this connection between the human papillomavirus and head and neck cancer. And since then we've seen this precipitous rise in the number of throat cancers specifically due to HPV. The results from the American Cancer Society showed last year that head neck cancer, in particular these cancers of the oropharynx, actually were one of the few cancers that still had an increasing incidence, I think it was around 2.5% per year. And other studies have shown that almost 50% of the cases we're seeing across the United States now are actually HPV-mediated throat cancers. That's bad news because we're seeing this rise in cases, but it's good news in the sense that this is a cancer that is highly curable and I think opens up a lot of different treatment avenues that we didn't have a couple of decades ago. And when patients are facing a mortality risk that's two or three times lower than the formerly HPV-negative smoking-driven cancers, it really behooves us as clinicians, as oncologists to think about treatment selection in a completely different way. And for years, the only function-sparing option, surgery certainly was not, was radiation therapy with concurrent cisplatin chemotherapy. In 2009, the FDA approved the use of surgical robotics using a transoral approach, a minimally invasive approach to resect the primary tumors and to perform neck dissection. And so now when patients walk in the door, they not only have this gold standard option in the path of radiation therapy with chemo, but also frontline surgery. And with some recent publications, especially the ECOG 3311 study, there's some really good evidence that for HPV-mediated throat cancers, we can actually de-escalate the intensity of adjuvant therapy when we start with surgery first. So who we choose that option for, which patients want that option - these are all really important new questions that we try to grapple with in these guidelines. Brittany Harvey: That background is really key for setting the stage for what we're about to talk about today. And so next I'd like to review the key recommendations across the clinical questions that the panel addressed. So you just talked about the importance of treatment selection. So to start that off, first, what is recommended for baseline assessment for patients with oropharyngeal squamous cell carcinoma who are being considered for transoral robotic surgery? Dr. Chris Holsinger: So I think here we tried in the guidelines to really standardize the workup and approach of this disease, in general, but with a strong focus on who might be a good surgical candidate. As I mentioned in the introduction, I mean, this is a disease that is very new. Our workup is in flux. And so what we tried to do, especially in items 1.2 and 1.3, is to really standardize and confirm that the tumor that we're dealing with, which oftentimes presents in a metastatic lymph node, is in fact associated with the human papillomavirus. So how biopsy is done, how high risk HPV testing is performed, whether you're doing that with an in situ hybridization, a DNA based study, or a p16 immunohistochemical study. And we try to tackle these issues first to really make sure that the patient population we're considering is actually indeed eligible for this kind of treatment de-escalation with surgery. Brittany Harvey: Understood. So it's important to consider which patients could be eligible for TORS upfront. So what is the role of TORS in patients with HPV-positive oropharyngeal squamous cell carcinoma? Dr. Chris Holsinger: Yeah, exactly. So I think first of all, surgery is ideally suited, and the robot is FDA approved for early-stage cancers - T1 and T2 cancers that are amenable to a minimally invasive approach. And we really try to emphasize, especially in our patient selection section of the guideline, who is really an ideal candidate for this. It's not just the T1 and T2 tumor. It's a tumor that is lateralized so that we can maybe consider managing the neck concurrently just on the side of the tumor, rather than doing bilateral neck dissection for most patients. Which patients might get the best functional outcome is a really critical component of this. And in fact, that actually goes back to a guideline that we didn't have time to chat about earlier, which is that we think every head neck cancer patient, whether or not they're being considered for transoral robotic surgery or frontline radiation therapy with cisplatin, every patient should have a pre-treatment assessment by a speech and swallowing expert. They're called different names across the country: speech language pathologists, speech pathologists, etc. But having a really good functional assessment of the patient's ability to swallow before treatment selection is really critical. And why that's important with frontline surgery is that there's a period of about one or two weeks after which that patient really needs intensive rehabilitation. And so for every patient being considered by TORS, we want to work really hand in hand with that speech pathologist to do pre-habilitation and then immediate post-operative rehab and then long longitudinal rehabilitation so that if radiation is needed down the road in a month, that patient just hopefully sails through this de-escalated treatment that we're offering. Brittany Harvey: Great. I appreciate you describing which patients can be considered for transoral robotic surgery. So beyond that, which patients with HPV-positive oropharyngeal squamous cell carcinoma aren't really good candidates for TORS? Dr. Chris Holsinger: We talked about that sort of ideal patient, but you know, we're not always living in an ideal world. And so I think it's important, and I'm really happy about the multidisciplinary discussions that led to these final guidelines because I think it helped engage radiation oncologists, medical oncologists, and surgeons around who's maybe not a good candidate for this because radiation therapy, with or without cisplatin chemotherapy, remains a good option for many of these patients. But I think the consensus, especially among the surgeons in this group, were that patients with tumors were more endophytic - that's the old fashioned oncology and surgical oncology term that refers to tumors that seem to not be as evident on the surface and have more of an infiltrative deep growth pattern - these are not ideal tumors. Whereas an exophytic tumor that's growing upwards, that's more readily seen on flexible endoscopy during a routine clinic assessment, or frankly, better seen on imaging, those exophytic tumors are better suited to a surgical approach because the surgeon has a better chance when he or she sees the tumor to get a good margin. When we can appreciate not just the surface mucosal margins that need to be taken, but also have a better chance to appreciate their depth. And with those infiltrative tumors, it's much harder to really understand how to get that deep margin, which in many cases is always the hardest. And so that's a long way to say that surgical decision making, patient selection is really critical when it comes to offering TORS as a multidisciplinary group. And then there are a few other things that we can quickly talk about before we move on to discussing adjuvant therapy. But I think there are some relative contraindications to patients who might have tumors arising in a palatine tonsil or tonsillar pillar, but which might grow significantly into the soft palate, such that a major palatal resection would be needed to get a good margin. For T1 and T2 tumors, we're not sure that that is an ideal candidate. And the other relative contraindication, but it's a hard and fast contraindication in my personal practice, is patients with extensive nodal disease. I think a patient who has preoperative extranodal extension, matted nodes, clinically and on MRI, you know pre-op they're going to need intensive post operative concurrent chemoradiation post-op that's maybe not the best patient for TORS, although there are some select cases where that that might make sense. But that's a quick overview of patient selection for TORS, Brittany. Hopefully, that's helpful. Brittany Harvey: That's definitely helpful. I think it's really important to consider not only who is eligible, but who isn't eligible for this de-escalation of treatment, and I appreciate you clarifying some of that. So then you've just also mentioned adjuvant therapy along with multidisciplinary discussion. So what is recommended regarding adjuvant therapy for patients who have resected HPV-positive oropharyngeal squamous cell carcinoma? Dr. Chris Holsinger: Definitely. And I think the post-operative discussion has to begin with great pre-op planning. And pre-op planning is really anchored in a really robust multidisciplinary team. So, we spoke earlier about the critical importance of getting speech language pathology involved initially, but they're part of a much larger team that includes not just a surgeon, but medical oncologist, a radiation oncologist and a dental oncologist - all of these specialties, and I could think of several others if we had time to chat further - this should also be really engaged in the care of these patients. But great decision making regarding adjuvant therapy really begins with a robust multidisciplinary consultation pre-op and we try to emphasize that in the guidelines. But just to return and answer your question very directly, I think adjuvant therapy is really the critical piece in getting that great functional outcome for a patient with HPV-mediated throat cancer. And I think traditionally patients who have a variety of different risks, based on a large study done again by the ECOG group, ECOG 3311, we showed that by stratifying patients based on their surgical pathology rather than on an estimate of disease extent, we can better stratify adjuvant therapy. And so the low risk patient is a patient with good margins and of course, good margin, we could spend another two hours discussing that. But good margins are greater than at least 1 to 3 millimeters superficially and a clear deep margin. Patients with lymph node metastases that are less than 3 cm and a single lymph node can sometimes be observed but most patients don't fall into that low risk category. Most patients fall into an intermediate risk where the margin is good and it's clear, but it might be close. That depends if you're talking about the superficial mucosal margin or the deep. But more often than not, we spend a lot of time considering the extent of lymph node involvement as it pertains to how adjuvant therapy is delivered. And I think for patients with less than 4 lymph nodes traditionally without extranodal extension, radiation therapy will suffice for adjuvant therapy after TORS. And the question of dose then comes up. Are we talking 50 Gray, the experimental arm that showed real promise in the ECOG 3311 trial, or 60 Gray or more traditional dose? And that is a topic definitely for another podcast, which we should do with a radiation oncologist online. I don't want to get into the weeds with that, but I refer you to our guidelines and Bob Ferris and Barbara Burtness' paper from JCO in 2021 for further details about that. But then for patients with positive margins with more than four lymph nodes, but especially patients with extranodal extension, the role of radiation therapy and chemotherapy is really absolutely critical. Because these patients and while they only accounted for around 20% to 30% of patients that we're seeing in this new era of TORS, they're the ones that we're really focusing on how can we do better because their overall survival is still good, it's 90%, but it's not as good as the patients we're seeing with a low and intermediate risk. So that's a brief overview there. Brittany Harvey: I appreciate that overview. And yes, we'll refer listeners to the full guideline, which is linked in the show notes of this episode to learn more about the intricacies of the radiation therapy that you mentioned. So then we've talked a lot about patients with HPV-positive disease, but what is the role of TORS in patients with HPV-negative disease? Dr. Chris Holsinger: I think TORS still has a role for these patients. Our colleague in India, Surender Dabas, has a really nice series that shows that for HPV-negative patients, this is a way for early stage cancers to potentially escalate the intensity of treatment for a disease that does worse than this new HPV-positive we're seeing in the US. So I think there's a good signal there. I think more study needs to be done and I think those studies, in fact, are underway in India and other countries. I hope that we can, as an oncology community here in the United States, also tackle this disease, which is still a significant part of the disease we face in head and neck oncology. Brittany Harvey: Yes, we'll look forward to more data coming out for HPV-negative disease. So then, the last clinical question that the guideline panel addressed: What is the role of TORS in the salvage or recurrent setting? Dr. Chris Holsinger: So we wrap up the guidelines tackling this topic. It's definitely something for the experienced TORS surgeon in consultation with that multidisciplinary team. Oftentimes, we are still seeing many patients who need salvage surgery and I think, while TORS alone could be a really effective treatment option, TORS with a microvascular reconstruction is oftentimes what is needed for these patients who, with recurrence, do often present with an RT 2, 3, 4 tumor. In my own practice, I found that using TORS as a way to minimize the superficial mucosal extent and then delivering that tumor through a traditional lateral pharyngotomy, then neck dissection and then having a microvascular flap inset done after that really provides the best possible chance for good long term function and of course control of the tumor. Here, I definitely refer the listener to some great work done out of the Royal Marsden with Vin Paleri, who we're happy to have on our TORS guideline panel for his RECUT study that really grapples in some detail with these very issues. Brittany Harvey: Excellent. And so we've covered a lot of the recommendations here that were made by the panel and you've touched a little bit about how this changes things for clinicians in practice. But what should clinicians know as they implement these new recommendations? Dr. Chris Holsinger: One thing as we close, I hope that in the future we can really start to grapple with this concept of patient selection. I think these guidelines help establish that TORS is a great oncologic option with - really the only option for treatment de-escalation in the here and now. Radiation therapy and cisplatin concurrent chemotherapy is going to be an option that is such an important choice for patients. And I think where I hope the field goes in the future is figuring out which patient wants one of these options. And I think certain patients really want that tumor taken out and others just the idea of surgery is not something that makes sense for them. How we in the context of a multidisciplinary team, really engage that patient, elicit their treatment preferences and then through considering treatment eligibility criteria that we've spelled out here for surgery and can be spelled out for chemo RT, bringing all that together in a formal shared decision making process is really where I hope the field will be going in the next few years. And hopefully these guidelines help to pave the way there. Brittany Harvey: Definitely the aspect of care by a multidisciplinary team and talking with patients to go through shared decision making is key to implementing these guidelines. So then, in that same vein, what do these recommendations mean for patients with oropharyngeal squamous cell carcinoma? Dr. Chris Holsinger: I think the central take home message for patients should be that especially if you have a T1 and T2 tumor, it's really important to have that consultation with a surgeon who knows how to do TORS and has a busy practice, but then also having an honest discussion up front about what the functional outcomes would be both with surgery and also chemo RT. And I think just knowing all those different options, that multidisciplinary treatment selection process is going to be that much more robust. And I think more right decisions will get made and we'll see less decisional regret down the road, which I think is a long term goal of our field. Brittany Harvey: Absolutely. That discussion of preferences is key. So then to wrap us up, you touched on this a little bit earlier in talking about ongoing research and data, particularly in the field of HPV-negative disease, but what are the outstanding questions regarding TORS in this patient population? Dr. Chris Holsinger: Yeah, I think that in addition to this work around shared decision making, I really hope that we'll embrace shared decision making in the context of future clinical trial. I think where we are now is you have surgeons saying, “Hey, TORS and 50 gray is a great option. Why aren't we doing that?” And then our colleagues, perhaps across the aisle, if I can use a political metaphor, are saying, “Well, where's the comparative data? Can we even do a randomized clinical trial between surgery and radiation?” Well, Christian Simon in Lausanne in Switzerland is trying to do this in a small pilot study being led by the EORTC, and I would encourage American investigators to consider something analogous. But I think how we solve this question of I think treatment choice is going to be pivotal for any such trial to ever be done. And then finally, I think, how will the changing treatment landscape around immunotherapy change this? There's some really provocative data that dates back to 1996 in a JCO paper from Ollivier Laccourreye and the University of Paris experience that showed induction chemotherapy followed by function preserving surgery in the larynx was a really powerful strategy for organ preservation, and that has never been followed up in the United States. And so especially with the upcoming presentation of KEYNOTE-689, will we be doing neoadjuvant approaches for patients and then following them by minimally invasive surgery or lower dose radiation? I think these are going to be some exciting new areas of study and I can't wait to see how this might evolve so we can refine the treatment - still get those great outcomes, but reduce those late toxicity. Brittany Harvey: Yes. We'll look forward to this ongoing research to continue to move the field forward. So, Dr. Holsinger, I want to thank you so much for your time to develop this important guideline. It's been great to have you on the podcast to discuss it today. Dr. Chris Holsinger: Well, thanks a lot Brittany. It's nice to finally meet you. Brittany Harvey: Likewise. And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/head-neck-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.

RUSH MD Anderson Cancer Center offers leading-edge treatments for GI cancers, including targeted therapies, immunotherapy, chemotherapy, and minimally invasive surgical options. Our multidisciplinary team of medical oncologists, gastroenterologists, surgical oncologists, colorectal surgeons and interventional radiologists work together to provide our patients with tailored treatment plans to each patient's specific diagnosis and needs. Audrey Kam, MD, is the director of GI medical oncology at RUSH MD Anderson, as well as the research director of GI medical oncology at RUSH MD Anderson. She specializes in treating gastrointestinal cancers including colorectal, esophageal, gastrointestinal, liver, pancreatic and stomach cancers. Sam Pappas, MD, is the Division Chief of Surgical Oncology at Rush University Medical Center. He specializes in treating upper abdominal cancers, including ones in the esophagus, stomach, pancreas, liver and bile duct. “We love collaborating in immediate proximity to each other within RUSH MD Anderson. This helps to ensure coordinated, multidisciplinary discussions that are patient-focused,” explains Dr. Pappas.

In 2024, only months before the world lost Dr. Nick Hopkins, Host John Murray, sat down with Dr. Hopkins to discuss his innovative treatments in stroke care, the necessity of collaboration and partnerships to advance research and clinical care, and the importance of mentorship and training the next generation of neurosurgeons. In this special memorial episode, we hear Dr. Hopkins reflect on “not doing everything by the book, but looking around to ask: is there a better way than what's in the book?” He shares his philosophy on embracing and learning from mistakes that have fueled advancements in neurovascular methodologies and inspired a culture of openness in the medical community. A champion of mentorship, Dr. Hopkins has acted as a guiding force for numerous professionals, shaping the future of neurovascular surgery. The episode also delves into the ethical and moral compass that underlies Dr. Hopkins' work, reaffirming the profound humanity that anchors his approach to both his profession and personal life. To honor the depth of Dr. Hopkins' legacy, we hear directly from many of his mentees and fellows, including Dr. Adnan Siddiqui, Dr. Ricardo Hanel, Dr. Chuck Kerber, Dr. J. Mocco, Dr. Qureshi, Dr. Raphael Rodriguez, Dr. Demetrius Lopes, and Dr. Ajay Wakhlo on the personal and professional impact he has had on their lives and careers. Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com. Special thanks to Dr. Hopkins's mentees and fellows who shared their stories and to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, and Dr. Elad Levy. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!

Multidisciplinary artist Ibe Ananaba describes getting early inspiration from his older brother, exploring different mediums and why his approach to painting is similar to carving. He also takes us on a deep dive into the thinking behind one of his paintings and a lesson he helped me learn from my first experience as a curator.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, epilepsy expert Depobam Samanta, MD, MS, FAAP, FAES, sat down to discuss a recently published guidance paper from members of the Pediatric Epilepsy Research Consortium that provides recommendations for neuromodulation approaches to treat Lennox-Gastaut syndrome (LGS). Samanta, medical director of the Arkansas Children's Comprehensive Epilepsy Program, gave a clinical overview of the paper, highlighting the various neuromodulatory devices and their use, and the ways to improve treatment selection and personalization. Additionally, he talked about some of the potential complications with these devices as well as initiation and titration strategies for easy initiation. Furthermore, he spoke about ways to take neuromodulation to the next level, giving insight on creative trial designs, overcoming sham-controlled studies, and the necessary research to expand these approaches.  Looking for more epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page. Episode Breakdown: 1:05 – Overview of the published guidance and reasons behind the paper  5:15 – Patient selection for neuromodulation and tailoring treatments by patient and preference 8:25 – Overcoming complications with neuromodulation devices  11:25 – Multidisciplinary team necessary for successful implementation of neuromodulation 13:15 – Neurology News Minute 15:15 – Initiation and titration strategies for vagus nerve stimulation, deep brain stimulation, and resective surgery 18:30 – Next steps in research and expanding neuromodulation for patients with LGS 21:10 – Finding creative trial designs to test neuromodulation devices, combination approaches The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Accepts BLA for Subcutaneous Autoinjector Formulation of Lecanemab Cell Therapy Bemdaneprocel Advances to Phases 3 Registrational Trial in Parkinson Disease Real-World Study Highlights Positive Treatment Benefits of Tofersen on ALS Disease Progression, Function Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator). Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion: https://www.cmeuniversity.com/course/take/125735 --- This podcast is supported by an educational grant from: AstraZeneca https://www.astrazeneca.com/our-therapy-areas/oncology.html With additional support from: Boston Scientific https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html --- SYNPOSIS The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient's medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient's understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers. --- TIMESTAMPS 00:00 - Introduction 00:46 - Multidisciplinary Tumor Board 06:00 - Patient Experience in Treatment Pathways 10:10 - Barriers to Treatment 16:03 - Benefits of IR Clinic 19:33 - HCC Screening and Risk Factors 24:08 - Building Referral Networks 30:34 - Strategies for Effective Scheduling 35:43 - The Future of HCC Treatment

Turning over to a new calendar brings about many declarations around changing habits and making improvements. But you don't have to create a wholly new version of yourself to do and be better. Nico Marie McNeese is known locally for her skills behind the turntables as DJ Nico Marie and as a yogi to her 190,000 followers on YouTube. She's combining her love of music, movement and mental wellness in her first album, “Meeting Myself For The First Time.” Multidisciplinary artist Damon Davis helped produce the album and joined her in conversation about the goals of this project and how they collaborated to bring the album to life.

In this episode, Dr. Sergio Zanotti discusses rational fluid therapy. He is joined by Dr. Adrian Wong, a practicing intensive care medicine and anesthesia physician. Dr. Wong is a consultant and clinical lead at King's College Hospital, London. He also serves as a committee member for the Intensive Care Society FUSIC, examiner for the European Diploma of Intensive Care Medicine, on the executive committee of the International Fluid Academy. Additional resources: Intravenous fluid therapy in the perioperative and critical care setting” Executive summary of the International Fluid Academy (IFA). Malbrain ML, et al. Ann. Intensive Care 2020: https://pubmed.ncbi.nlm.nih.gov/32449147/ Multidisciplinary expert panel report on fluid stewardship: perspectives and practice. Malbrain ML, et al. Annals of Intensive Care 2023: https://pubmed.ncbi.nlm.nih.gov/37747558/ The emerging concept of fluid tolerance: A position paper. Kattan E, et al. Journal of Critical Care 2022: https://pubmed.ncbi.nlm.nih.gov/35660844/ Everything you need to know about derescuscitation. Malbrain ML, et al. Intensive Care Med 2022: https://pubmed.ncbi.nlm.nih.gov/35932335/ Start with Why. TED Talk presented by Simon Sinek: https://simonsinek.com/videos/ted-talks/ Books mentioned in this episode: Thinking Fast and Slow. By Daniel Kahneman: https://amzn.to/4hicUoj Start with Why: How Great Leaders Inspire Everybody to Take Action. By Simon Sinek: https://bit.ly/42hzt8n

Having a healthy voice is important for everyone, whether you are a professional singer, teacher, salesperson or simply like to read aloud to your grandchildren. Similarly, our ability to swallow is an essential part of everyday life and when comprised can feel frustrating and even embarrassing in public settings. If you suffer from hoarseness or trouble with your voice or throat, our team of expert ENT providers can help. We provide comprehensive care for voice and swallowing disorders. Omid Mehdizadeh, MD is our fellowship trained laryngologist who specializes in voice and swallowing treatment and care.

Michaell Magrutsche (mag-rootsh) is a neurodiverse multidisciplinary artist, strategist (private, corporate and political) Creativity-Awareness Educator. ------------------ Find a Virtual Assistant at va.world -------------------    Upgrade Your Brain  Unleash & Use Your Uniqueness    ⁠⁠https://braingym.fitness/⁠⁠   http://partnerco.world/   All about Roy https://roycoughlan.com/ ------------    Speaking Podcast Social Media / Coaching My Other Podcasts  ⁠⁠⁠⁠https://roycoughlan.com/⁠⁠⁠  ------------------    About my Guest Michaell Magrutsche : Michaell Magrutsche (mag-rootsh) is a neurodiverse multidisciplinary artist, strategist (private, corporate and political) Creativity-Awareness Educator. Michaell works on raising the awareness of our limitless human-potential. Dyslexia/dysgraphia forced Michaell to develop an awareness to see the world contextually. Having a more human-centric perspective and art-creation saved his life feeling like a human being instead of an outcast.  Today, Michaell's unique comprehension allows him to contribute to almost every topic. Michaell is an advocate for human-education and understanding neurodiversity. Michaell is totally self-taught and wrote 6 books about art and humanity, man-made systems and human inclusivity. Creating-art taught him understanding the nuances of human-centric vs system-relevant living.  In his book The Smart of Art, Michaell refines the misunderstanding of why 98-99% of artists worldwide exist around the poverty-level. What we Discussed:      - Realising his disability and how Art saved him (1:30 mins) - Find out what a Producer is (5:20 mins) - Most Artists are poor (8:15 mins) - What he started painting Garage Doors (10:45 mins) - What he trying to do with Pre School education (13 mins) - The hatred with some sport supporters (22:45 mins) - Human Super Powers (25:30 mins) - Why he has 30 second episode podcasts (28 mins) - Adaptibility (30:45 mins) - Why not to script podcasts (32:30 mins) - Coming last in the class to 1st (34 mins) - The Process of Art (42 mins) - How to know the best Artist Educator (49:45 mins) - Do we really need a car (55 mins)   Where to find Michaell Magrutsche :   https://michaellm.com/ https://podcasters.spotify.com/pod/show/michaellart LinkedIn: https://www.linkedin.com/in/michaellart Instagram: https://instagram.com/thesmartofart/ YouTube Videos: https://goo.gl/gPM7cq Twitter: https://twitter.com/michaellart Facebook https://www.facebook.com/Michaellcoach My Music: www.soundcloud.com/michaellart My Books: https://goo.gl/tpDQk3 ------------------------------ More about the Awakening Podcast: All Episodes can be found at ⁠⁠http://www.speakingpodcast.com/⁠⁠   All Social Media + Donations link ⁠⁠https://bio.link/podcaster⁠⁠   https://roycoughlan.com/ Our Facebook Group can be found at ⁠⁠https://www.facebook.com/speakingpodcast⁠

Globally, it is estimated that over 1 billion children experience some form of abuse each year. This includes physical, sexual, emotional abuse, and neglect. These numbers are likely underreported due to stigma, lack of reporting mechanisms, and other barriers that prevent children from speaking out. In this video, we share exciting news about the upcoming opening of a Children's Justice Center, also known as a Children's Advocacy Center. This vital new resource will provide a safe, child-friendly environment where child victims of sexual and physical abuse can receive physical and forensic examinations, as well as emotional support. The center is designed to help children prepare for court while ensuring they get the care and justice they deserve. Watch to learn more about the impact this center will have on our community and how it will help children heal and seek justice. #ChildAdvocacy #JusticeForChildren #ChildAbuseAwareness #CommunitySupport #ForensicExaminations #SafeSpaces #Children's Justice Center #Children's Advocacy Center #Child abuse support #Sexual abuse recovery #Physical abuse recovery #Safe space for children #Child abuse survivors #Trauma-informed care #Child safety and protection #Child forensic interviews #Healing after abuse #Support for abused children #Helping child survivors #Legal advocacy for children #Child-friendly environment #Multidisciplinary team #Child abuse prevention #Therapy for abused children #Child protection services #Reporting child abuse #Emotional support for kids #Counseling for trauma #Safe place for children to talk #Empowering child survivors #Abuse recovery programs #Specialized care for children #Justice for abused children #Child-focused investigation #Helping children heal #Protecting vulnerable children=======================================Order a copy of Deceived or She Knew No Fear and get the book signed for free! https://www.ProfilingEvil.comDONATE to Profiling Evil: https://www.paypal.com/donate/?hosted_button_id=PK7KKA55V8PENSUPPORT our Podcasts: https://www.buzzsprout.com/1213394/support

Multidisciplinary artist Jackie Amézquita returns to discuss the birth of her baby in this "after birth" story. Connect with Jackie: jackieamezquita.com and @jackieamezquita Want more pregnancy + parenting? Informed Pregnancy Plus is a new streaming platform by pregnancy focused chiropractor Dr. Elliot Berlin. Dedicated to pregnancy, parenting, and everything in between, IP+ offers everything from prenatal workouts and yoga flows to original series and iconic birth films like The Business of Being Born. (Pssst, subscriptions are a great gift for parents-to-be!) Start your FREE TRIAL of Informed Pregnancy+ and get access to all our curated pregnancy and parenting content HERE!  Keep up with Dr. Berlin and the Informed Pregnancy Project online! informedpregnancy.com Informed Pregnancy on Youtube Informed Pregnancy Media on LinkedIn @doctorberlin Facebook X Learn more about your ad choices. Visit megaphone.fm/adchoices

Multidisciplinary artist Jackie Amézquita returns to discuss the birth of her baby in this "after birth" story. Want more pregnancy + parenting? Informed Pregnancy Plus is a new streaming platform by pregnancy focused chiropractor Dr. Elliot Berlin. Dedicated to pregnancy, parenting, and everything in between, IP+ offers everything from prenatal workouts and yoga flows to original series and iconic birth films like The Business of Being Born. (Pssst, subscriptions are a great gift for parents-to-be!) Start your FREE TRIAL of Informed Pregnancy+ and get access to all our curated pregnancy and parenting content HERE!  Keep up with Dr. Berlin and the Informed Pregnancy Project online! informedpregnancy.com Informed Pregnancy on Youtube Informed Pregnancy Media on LinkedIn @doctorberlin Facebook X Learn more about your ad choices. Visit megaphone.fm/adchoices